Related Experiment Video
Updated: Aug 7, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
[Intravitreal application of triamcinolone--our experiences]
Slavica Konjević Pernar1, Zoran Vatavuk, Goran Bencić
1Klinika za ocne bolesti, Klinicka bolnica Sestre milosrdnice, Zagreb, Hrvatska.
Summary
Intravitreal triamcinolone injections effectively reduced macular edema and improved vision in patients with various ocular conditions. This treatment demonstrated safety and efficacy, with transient intraocular pressure rise as the main complication.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Context:
- Ocular disorders like exudative age-related macular degeneration, diabetic retinopathy, and central retinal vein occlusion pose significant visual threats.
- Intravitreal therapies are crucial for managing these sight-threatening conditions.
Purpose:
- To evaluate the efficacy and safety of intravitreal triamcinolone acetonide as a primary or adjuvant therapy for ocular disorders.
- To assess the impact of intravitreal triamcinolone on macular edema, visual acuity, and complications.
Summary:
- Intravitreal triamcinolone acetonide demonstrated a marked reduction in macular edema in 70% of patients, confirmed by fluorescein angiography.
- Visual acuity improved in 62% of treated patients.
- The most frequent complication was a transient increase in intraocular pressure; no cases of endophthalmitis were reported.
Impact:
- Intravitreal triamcinolone acetonide is a relatively safe and effective treatment option for selected patients with diverse ocular pathologies.
- This therapy offers a viable approach to preserving and improving vision in patients with retinal vascular diseases and macular edema.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...